The following tables describe changes to the 麻豆官方Pharmacologic-Therapeutic Classification漏 that will be published in the 2021 edition of 麻豆官方Drug Information庐 (February 1, 2021), as well as any new classes added after the publication of the 2020 edition. This is only a partial listing of the 麻豆官方PTC. The full classification system, along with a list of drugs covered in 麻豆官方DI and their corresponding classes, is available in the printed edition and is available electronically in a separate file. Reproduction, storage on a retrieval system, or transmission of this material or any part thereof in any form or by any means without the express written permission of the 麻豆官方 is prohibited.
Please contact ASHP eHealth Solutions Division at +1 (301) 664-8860 for more detailed information.
Drug Assignments
| wdt_ID | Drug Name | Active Ingredients | Company | Indication | Approval Date | 麻豆官方Class | NDA Type | Appl No |
|---|---|---|---|---|---|---|---|---|
| 1 | Skyla® | levonorgestrel | Bayer | birth control | 01/09/2013 | 68:12 - Contraceptives | 5 | |
| 2 | Uceris® | budesonide extended-release tablets | Santarus | ulcerative colitis | 01/14/2013 | 68:04 - Adrenals | 5S | |
| 3 | Zecuity® | sumatriptan | Nupathe | migraine headache | 01/17/2013 | 28:32.28 - Selective Serotonin Agonists | 3 | |
| 4 | Nesina® | alogliptin | Takeda | type 2 diabetes mellitus | 01/25/2013 | 68:20.05 - DPP-4 Inhibitors | 1 | |
| 5 | Oseni® | alogliptin; pioglitazone | Takeda | type 2 diabetes mellitus | 01/25/2013 | 68:20.05 - DPP-4 Inhibitors; 68:20.28 - Thiazolidinediones | 1 | |
| 6 | Kazano® | alogliptin; metformin | Takeda | type 2 diabetes mellitus | 01/25/2013 | 68:20.05 - DPP-4 Inhibitors; 68:20.04 - Biguanides | 1 | |
| 7 | Kynamro® | mipomersen | Genzyme | homozygous familial hyper-cholesterolemia (HoFH) | 01/29/2013 | 24:06.92 - Antilipemic Agents, Miscellaneous | 1 | |
| 8 | Ravicti® | glycerol phenylbutyrate | Hyperion | urea cycle disorders (UCD) | 02/01/2013 | 40:10 - Ammonia Detoxicants | 2S/O | |
| 9 | Delzicol® | mesalamine | Warner Chilcott | ulcerative colitis | 02/01/2013 | 56:36 - Anti-inflammatory Agents | 3S | |
| 10 | Versacloz® | clozapine | Douglas | schizophrenia | 02/06/2013 | 28:16.08.04 - Atypical Antipsychotics | 3 | |
| Drug Name | Active Ingredients | Company | Indication | Approval Date | 麻豆官方Class | NDA Type | Appl No |
Drug Reassignments
| wdt_ID | Drug Name | Active Ingredients | Change Date | Old 麻豆官方Class | New 麻豆官方Class |
|---|---|---|---|---|---|
| 1 | Adipex®, Ionamin® | phentermine | 01/01/2013 | 28:20.92 | 28:20.08.04 |
| 2 | Adipost®, Bontril® | phendimetrazine | 01/01/2013 | 28:20.92 | 28:20.08.04 |
| 3 | Amoply® | ammonia spirit, aromatic | 01/01/2013 | 28:20.92 | 28:20.32 |
| 4 | Belviq® | lorcaserin | 01/01/2013 | 28:20.92 | 28:20.08.32 |
| 5 | Cafcit®, No Doz®, Vivarin® | caffeine/ caffeine and sodium benzoate | 01/01/2013 | 28:20.92 | 28:20.32 |
| 6 | Concerta®, Daytrana®, Metadate®, Methylin®, Ritalin® | methylphenidate | 01/01/2013 | 28:20.92 | 28:20.32 |
| 7 | Dopram® | doxapram | 01/01/2013 | 28:20.92 | 28:20.32 |
| 8 | Focalin® | dexmethylphenidate | 01/01/2013 | 28:20.92 | 28:20.32 |
| 9 | Kalydeco® | ivacaftor | 01/01/2013 | 48:92 | 48:14.12 |
| 10 | Nuvigil® | armodafinil | 01/01/2013 | 28:20.92 | 28:20.80 |
| Drug Name | Active Ingredients | Change Date | Old 麻豆官方Class | New 麻豆官方Class |
麻豆官方Class Changes
| wdt_ID | 麻豆官方Class | Change Date | Change Description |
|---|---|---|---|
| 1 | 28:20 - Anorexigenic Agents and Respiratory and CNS Stimulants | 01/01/2013 | Name Change |
| 2 | 28:20.08 - Anorexigenic Agents | 01/01/2013 | New classification |
| 3 | 28:20.08.04 - Amphetamine Derivatives | 01/01/2013 | New classification |
| 4 | 28:20.08.32 - Selective Serotonin Receptor Agonists | 01/01/2013 | New classification |
| 5 | 28:20.32 - Respiratory and CNS Stimulants | 01/01/2013 | New classification |
| 6 | 28:20.80 - Wakefulness-promoting Agents | 01/01/2013 | New classification |
| 7 | 28:20.92 - Anorexigenic Agents and Stimulants, Miscellaneous | 01/01/2013 | Name Change |
| 8 | 48:14 - Cystic Fibrosis Transmembrane Conductance Regulator Modulators | 01/01/2013 | New classification |
| 9 | 48:14.04 - Cystic Fibrosis Transmembrane Conductance Regulator Correctors | 01/01/2013 | New classification |
| 10 | 48:14.12 - Cystic Fibrosis Transmembrane Conductance Regulator Potentiators | 01/01/2013 | New classification |
| 麻豆官方Class | Change Date | Change Description |